Page 85 - Biotech Networks Virtual Speed Networking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech networks virtual speed networking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Networks Virtual Speed Networking Today - Breaking & Trending Today

21st Austria weekly - Marinomed, Austrian Post (18/12/2023)

21st Austria weekly - Marinomed Austrian Post 18/12/2023 [pic1]Marinomed: Marinomed Biotech AG considers strategic options for its Carragelose business and has mandated an external advisor. A structured process was initiated in which the advisor will start engaging with potential partners. This initiative meets attractive market environment those assets that comply new EU medical device regulation MDR. In May 2024 important interim period ends imposing challenging requirements all devices. Products don’t fulfil these lose their certificate must not be marketed. products necessary prerequisites MDR are backed by extensive clinical data comprising >1000 patients 12 international trials. is a unique patent-protected broadly active virus-blocking compound currently used marketed product portfolio prophylaxis treatment of viral respiratory infections. Recent data also support extension using Allergy Eye ....

Pascal Schmidt , Liechtensteinische Landesbank , Liechtensteinischen Landesbank , Walter Oblin , Mail Division , Marinomed Biotech , Eye Care , Supervisory Board , Austrian Post , Management Board , Chief Financial Officer , Deputy Chief Executive Officer , Management Board Member , Austria Weekly , Besuchen Sie , Ic1 Marinomed ,